Education
About Us
Working with TipRanks
Follow Us
Isofol Medical AB (DE:5IU)
:5IU
5IU Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.04 - €0.39
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€27.77M
Enterprise Value€262.41M
Total Cash (Recent Filing)kr138.15M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta0.03
Next Earnings
May 21, 2025EPS EstimateN/A
Last Dividend Ex-Date
Feb 14, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding161,515,440
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.64
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
5IU FAQ
What was Isofol Medical AB’s price range in the past 12 months?
Isofol Medical AB lowest stock price was €0.04 and its highest was €0.39 in the past 12 months.
What is Isofol Medical AB’s market cap?
Isofol Medical AB’s market cap is €27.77M.
When is Isofol Medical AB’s upcoming earnings report date?
Isofol Medical AB’s upcoming earnings report date is May 21, 2025 which is in 25 days.
How were Isofol Medical AB’s earnings last quarter?
Isofol Medical AB released its earnings results on Feb 19, 2025. The company reported -€0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.007.
Is Isofol Medical AB overvalued?
According to Wall Street analysts Isofol Medical AB’s price is currently Overvalued.
Does Isofol Medical AB pay dividends?
Isofol Medical AB pays a Notavailable dividend of €0.069 which represents an annual dividend yield of N/A. See more information on Isofol Medical AB dividends here
What is Isofol Medical AB’s EPS estimate?
Isofol Medical AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Isofol Medical AB have?
Isofol Medical AB has 161,515,440 shares outstanding.
What happened to Isofol Medical AB’s price movement after its last earnings report?
Isofol Medical AB reported an EPS of -€0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 14.286%.
Which hedge fund is a major shareholder of Isofol Medical AB?
Currently, no hedge funds are holding shares in DE:5IU
---
Company Description
Isofol Medical AB
Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candidate Modufolin enhances the effect of the current chemotherapy treatment for patients treated for colorectal cancer. It's products used for increase efficacy and reduce the side effects of antimetabolite cancer treatment.
---
Technical Analysis
Xbrane Biopharma AB
―
Xintela AB
―
Ascelia Pharma AB
―
Guard Therapeutics International AB
―
Immunicum AB
―
---